Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
Br J Psychiatry
; 217(3): 471-474, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32362299
ABSTRACT
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Anxiety
/
Pneumonia, Viral
/
Psychotherapy
/
Psychotropic Drugs
/
Practice Patterns, Physicians'
/
Coronavirus Infections
/
Pandemics
/
Mental Disorders
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Year:
2020
Type:
Article